Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
How Care Works
Virtual & Home Visits
Virtual care across 40 states + house calls in Philadelphia
Concierge vs. Direct Care
Zero visit copays, zero hidden fees, relationship model
Send Medical Records
Securely upload prior labs & notes before consultation
Common Questions (FAQ)
PCP scope, insurance, labs & cancellation policies
Services
Primary Care & Acute Visits
Same-day sick visits, refills & comprehensive PCP care
Chronic & Complex Care
POTS, MCAS, Long COVID, Lyme & fatigue workups
Hormones & Endocrine
TRT, thyroid, perimenopause, menopause & PCOS
Metabolic Health & Weight
Advanced lipid testing, GLP-1s & glucose monitoring
Longevity & Prevention
Medicine 3.0 baselines, VO2 max, DEXA & prevention
All Clinical Services
Comprehensive catalogue of 36+ clinical services
Membership
Membership Details
Unlimited direct access, continuous physician care
Care Packages
The Reset & Strategic Roadmap evaluations
Billing & Payment FAQ
HSA/FSA eligibility, transparent cancellation policy
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
Clinical Library & Articles
Evidence-based health guides reviewed by Dr. Ash
What People Say
124 patient reviews across 6 platforms
Contact Dr. Ash
Reach out with questions or book an intro
Patient PortalStart Intake

Fishtown Medicine Library

The Engine Room

Stop blaming your age. Fix your engine.

Insulin Resistance at a Normal Weight and a Normal A1c
Featured Metabolic Health Guide

Insulin Resistance at a Normal Weight

A study of 6,247 young adults without diabetes found 4 in 10 had insulin resistance, and close to half were not obese. What that means for your labs.

Read Full Guide
What to Eat: Big Breakfast Ideas and a Food-First Guide
Metabolic Health

What to Eat, Starting With Breakfast

The 5 food groups you can eat freely, why breakfast should be your biggest meal, and a long list of breakfast options that are more than a small yogurt.

Read Article
Amycretin: Novo Nordisk's Amylin/GLP-1 Drug, in a Pill and a Shot | Philadelphia
Metabolic Health

Amycretin: The Amylin/GLP-1 Drug That Comes as a Pill

Amycretin (zenagamtide) is Novo Nordisk's investigational amylin/GLP-1 co-agonist, in both an injection and an oral tablet. What the early-phase trials showed, why the pill matters, how it differs from CagriSema, and the early-stage caveats.

Read Article
Are Artificial Sweeteners and Erythritol Safe? What the Evidence Says | Philadelphia
Metabolic Health

Artificial Sweeteners and Erythritol: What the Evidence Says

Stevia, erythritol, aspartame, allulose - are they safe? A grounded look at the erythritol clotting scare, the aspartame cancer headlines, and what the best evidence shows, from Fishtown Medicine in Philadelphia.

Read Article
CagriSema (Cagrilintide + Semaglutide): REDEFINE Phase 3 Data | Philadelphia
Metabolic Health

CagriSema Cuts Weight 20 to 23% and Reverses Prediabetes in 88%: What REDEFINE 1-4 Show vs. Tirzepatide

CagriSema pairs the long-acting amylin analog cagrilintide with semaglutide. What REDEFINE 1 (-22.7% weight loss, 88% prediabetes reversal, -10.9 mmHg BP) and head-to-head REDEFINE 4 vs. tirzepatide prove.

Read Article
Compounded Semaglutide and Tirzepatide: Are They Safe and Legal in 2027? | Philadelphia
Metabolic Health

Compounded GLP-1 Drugs: Safe? Legal? Where Rules Stand in 2027

Compounded semaglutide and tirzepatide after shortages ended: legal limits since 2025 and 2026, documented safety risks, self-pay prices, and what to ask your doctor.

Read Article
GLP-1 Drugs and Surgery: Do You Stop Ozempic Before a Procedure? | Philadelphia
Metabolic Health

GLP-1 Drugs and Surgery: Do You Have to Stop Before a Procedure?

Most people can safely continue Ozempic, Wegovy, or Mounjaro before surgery. The 2024 multisociety guidance, why the old week-long hold is out of date, the aspiration risk, and how your care team decides.

Read Article
Mazdutide: The GLP-1/Glucagon Drug Approved in China | Philadelphia
Metabolic Health

Mazdutide: The Oxyntomodulin Drug Approved in China

Mazdutide is a GLP-1/glucagon dual agonist approved in China for weight and diabetes but not the US. What the GLORY-1 trial showed, its effects on uric acid and lipids, how it compares with survodutide and retatrutide, and its status.

Read Article
The New Weight-Loss Drugs, Compared (2027) | Philadelphia
Metabolic Health

The New Weight-Loss Drugs, Compared (2027)

Semaglutide, tirzepatide, orforglipron, retatrutide, and CagriSema compared: mechanism, weight loss, route, and approval status. Which is strongest, which is a pill, which has proven heart benefit, and how to choose.

Read Article
Orforglipron (Foundayo) vs. Oral Semaglutide (Wegovy Pill): Phase 3 Data | Philadelphia
Metabolic Health

Orforglipron (Foundayo) Drops Weight 11.2% With Zero Fasting Rules: How It Compares to Oral Semaglutide

FDA-approved in April 2026, Foundayo (orforglipron) is the first non-peptide GLP-1 pill taken with or without food. What ATTAIN-1/2 and head-to-head ACHIEVE-3 vs. oral semaglutide show.

Read Article
Resmetirom (Rezdiffra): The First Approved MASH Drug | Philadelphia
Metabolic Health

Resmetirom Clears Liver Fat and Regresses MASH Scarring While Lowering ApoB and Lp(a)

Resmetirom (Rezdiffra) is the first FDA-approved liver-directed THR-beta agonist for MASH with F2-F3 fibrosis. Dr. Ash breaks down the Phase 3 MAESTRO-NASH trial, LDL-C reduction (-13.6 to -16.3%), VCTE 8-15 kPa selection, free T4 interpretation, and how it compares with semaglutide.

Read Article
Retatrutide: Triple Agonist (GIP/GLP-1/Glucagon) Phase 3 Data | Philadelphia
Metabolic Health

Retatrutide Cuts Weight 25 to 28% and Clears 86% of Liver Fat: What the Phase 3 TRIUMPH Trials Show

Retatrutide is Eli Lilly's GIP/GLP-1/glucagon triple agonist. What Phase 3 TRIUMPH-1 (-28.3% weight loss) and the Nature Medicine MASLD MRI study (-86% liver fat) prove, plus heart-rate and skin-tingling trade-offs.

Read Article
Can You Reverse Type 2 Diabetes? What Remission Really Means | Philadelphia
Metabolic Health

Can You Reverse Type 2 Diabetes? What Remission Really Means

Type 2 diabetes can go into remission for many people through substantial weight loss. What the DiRECT trial showed, why doctors say remission instead of cure, the GLP-1 nuance, who is most likely to succeed, and how durable it is.

Read Article
Semaglutide (Ozempic) for Kidney Disease: The FLOW Trial & 2026 CKM Guidelines | Philadelphia
Metabolic Health

Semaglutide Cuts Kidney Failure Risk 24% and All-Cause Death 20%: What FLOW Proves for Diabetic Kidney Disease

In the FLOW trial (n=3,533), semaglutide 1.0 mg cut major kidney events by 24% (NNT 20), CV death by 29%, and overall death by 20% with zero initial eGFR dip and Cystatin C confirmation.

Read Article
Semaglutide (Wegovy) for MASH: The GLP-1 Fatty-Liver Drug | Philadelphia
Metabolic Health

Weekly Semaglutide Resolves MASH in 63% of Patients and Regresses Liver Scarring in the ESSENCE Trial

Semaglutide 2.4 mg (Wegovy) earned FDA approval for MASH with F2-F3 fibrosis in August 2025. Dr. Ash explains the Phase 3 ESSENCE trial (62.9% MASH resolution, 36.8% fibrosis improvement), non-biopsy VCTE 8-15 kPa selection, and how it compares with resmetirom and tirzepatide.

Read Article
Survodutide: The GLP-1/Glucagon Dual Agonist for Weight and Liver | Philadelphia
Metabolic Health

Survodutide Pairs GLP-1 Appetite Control With Direct Liver Glucagon Signaling to Clear MASH in Over 60% of Patients

Survodutide is Boehringer Ingelheim's investigational GLP-1/glucagon dual agonist. Dr. Ash breaks down the Phase 2 MASH biopsy trial (47%, 62%, and 43% vs 14% placebo), the 2026 SYNCHRONIZE-MASLD Phase 3 MRI-PDFF trial (84.2% fat reduction), direct liver glucagon signaling, and LIVERAGE Phase 3 trials.

Read Article
Tirzepatide (Zepbound, Mounjaro): Weight, Heart, Liver, and SURMOUNT-OSA
Metabolic Health

Tirzepatide (Zepbound, Mounjaro): The Dual Incretin Drug

Tirzepatide (Zepbound, Mounjaro) is the dual GIP/GLP-1 drug that beat semaglutide in SURMOUNT-5 (20.2% vs 13.7% weight loss) and earned FDA approval for moderate-to-severe sleep apnea in SURMOUNT-OSA (-51% to -59% AHI).

Read Article
Acarbose for Longevity: What the Evidence Shows | Philadelphia
Metabolic Health

Acarbose: The Diabetes Drug With a Longevity Signal

Acarbose is an old diabetes drug with a striking mouse-longevity signal. What it does, why longevity researchers watch it, what it is proven to do in people (diabetes prevention rather than heart protection), and its side effects.

Read Article
Fatty Liver (MASLD): Is It Serious and Can It Be Reversed? | Philadelphia
Metabolic Health

Half of Fatty Liver Cases Hide Behind a Normal ALT, and a 10% Weight Loss Resolves MASH in 90% of Patients

Standard lab ALT cutoffs (40 to 55 U/L) miss up to half of fatty liver (MASLD) and MASH cases. Dr. Ash explains healthy ALT ranges, 2-step FIB-4 and FibroScan staging, the 10% weight-loss curve, and FDA-approved MASH drugs.

Read Article
Finerenone (Kerendia): Protecting the Kidney and Heart | Philadelphia
Metabolic Health

Finerenone (Kerendia): The Kidney-and-Heart Drug for Diabetes

Finerenone (Kerendia) protects the kidneys and heart in diabetic kidney disease, and now in heart failure. How it works, what the trials showed, the high-potassium caution, and how it fits with SGLT2 inhibitors.

Read Article
GLP-1 Microdosing: What It Is and Whether It's Worth It | Philadelphia
Metabolic Health

GLP-1 Microdosing: What It Is and Whether It's Worth It

GLP-1 microdosing uses lower-than-standard doses for metabolic and longevity goals instead of maximum weight loss. What the evidence does and doesn't show, who it might fit, and how Fishtown Medicine approaches it in Philadelphia.

Read Article
Will You Lose Muscle and Bone on a GLP-1? The STEP-1 & SURMOUNT-1 Data and How to Protect Both | Philadelphia
Metabolic Health

Protecting Muscle, Bone, and Gallbladder on a GLP-1

In STEP-1 (semaglutide) and SURMOUNT-1 (tirzepatide), 26% to 39% of weight lost was DEXA lean mass. See how exercise and 1.6 to 2.0 g/kg protein protect muscle and hip/spine bone density (S-LiTE and LITOE trials), and how slow flexible titration prevents nausea and gallstones.

Read Article
GLP-1 Medications vs Bariatric Surgery: Which Is Right? | Philadelphia
Metabolic Health

GLP-1 Medications vs Bariatric Surgery: How to Choose

GLP-1 medications and bariatric surgery both drive major weight loss and can reverse diabetes, but they differ in size, durability, and trade-offs. How they compare, who fits which, and how Fishtown Medicine helps you decide.

Read Article
SGLT2 Inhibitors (Jardiance, Farxiga): Heart, Kidney, Longevity | Philadelphia
Metabolic Health

SGLT2 Inhibitors: Heart, Kidney, and the Longevity Question

SGLT2 inhibitors (Jardiance, Farxiga) protect the heart and kidneys, even in people without diabetes, and carry a mouse-longevity signal. The trial evidence, the longevity question, dosing, and the safety points that matter.

Read Article
Ultra-Processed Food: Why It Drives Weight Gain and Disease | Philadelphia
Metabolic Health

Ultra-Processed Food: What It Does to Your Health

Ultra-processed foods make up most of the American diet and are tied to weight gain, diabetes, and heart disease. What counts as ultra-processed, why it overrides your appetite, and how Fishtown Medicine helps you cut it in Philadelphia.

Read Article
High Uric Acid: Fructose, Insulin Resistance, Null Trials & Gout | Philadelphia
Metabolic Health

High Uric Acid Without Gout Signals High Insulin and Fructose - Fix the Metabolism Instead of Taking Pills

High serum uric acid tracks fasting insulin (r = -0.69 clearance; +1.18 mg/dL per SD in Mendelian randomization) and liquid fructose ATP depletion, yet 4 major trials (ALL-HEART, PERL, CKD-FIX, FEATHER) show allopurinol does not prevent heart or kidney disease without gout. How we treat the root cause.

Read Article
Ozempic, Wegovy, and Mounjaro: The Missing Manual
Metabolic Health

The GLP-1 Strategy

Why prescribing the shot is the easy part. Learn how we manage muscle preservation, protein intake, and the exit strategy for sustainable results.

Read Article
Ozempic vs. Metformin | Strategic Guide for Metabolic Health
Metabolic Health

Ozempic vs. Metformin: Which Strategy Wins?

Should you start with the foundation (Metformin) or the heavy hitter (GLP-1)? We break down signaling, metabolic impact, and sustainability.

Read Article
Medical Weight Loss & Body Composition | Philadelphia
Metabolic Health

Weight Loss That Works

A nuance-first approach to GLP-1s. We focus on body composition, not just the number on the scale, with HAES-aligned principles that prioritize health.

Read Article
Metabolic Health & Insulin Resistance Philadelphia | Longevity
Metabolic Health

Metabolic Flexibility: The Holy Grail

Weight is a lagging indicator. Insulin is a leading indicator. We use fasting insulin, CGMs, and DEXA scans to find and fix metabolic dysfunction.

Read Article
Metabolic Reset & Better Biology | Philadelphia
Metabolic Health

Metabolism: Getting Your Engine Working Right

A grounded clinical approach to metabolic health and GLP-1s. We focus on biological restoration and body composition, fixing the engine first.

Read Article
The Autoimmune Protocol (AIP) Diet: A Reset for Your Immune System
Metabolic Health

The AIP Diet: Immune Reset

More than just clean eating. Discover how the Autoimmune Protocol (AIP) acts as a diagnostic tool to silence inflammation and identify your specific dietary...

Read Article
The Anxiety-Gut Connection: Its Not 'All in Your Head'
Metabolic Health

Anxiety & The Gut-Brain Axis

Discover why your anxiety might be a microbial problem. Explore the Psychobiotic revolution and how the Vagus Nerve connects your gut to your brain.

Read Article
Fasting Protocols: Autophagy, Muscle, and the Goldilocks Zone
Metabolic Health

Fasting Protocols: The Goldilocks Zone

Fasting is a tool you can learn to use with care. Here is how to run time-restricted eating, 24-hour fasts, and longer protocols safely while protecting your muscle.

Read Article
IBS vs. SIBO: Why Your IBS Might Be Bacterial Overgrowth
Metabolic Health

IBS & SIBO: The Root Cause

Bloated after every meal? Up to 60% of IBS cases may be SIBO. Learn how we test, treat, and prevent recurrence.

Read Article
The Truth About Leaky Gut (Intestinal Permeability)
Metabolic Health

Leaky Gut: The Science of Permeability

Pseudoscience or real biology? Learn the science of zonulin and how intestinal permeability drives autoimmune disease and chronic inflammation.

Read Article
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
2418 E York St, Philadelphia, PA 19125(267) 360-7927Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health LiteracyClinical Evidence & Research

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical IndependenceCare NetworkResearch & Monographs